Longeveron Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
LGVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1951 Nw 7 Th Avenue, Suite 520, Miami, FL

Insiders trading volume in the past year

Longeveron Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joshua Hare Chief Scientific Officer, Director, 10%+ Owner $11.5M Aug 15, 2024
Donald M. Soffer Director $8.76M Dec 21, 2022
Rock Soffer Director $1.31M Aug 15, 2024
Paul T. Lehr General Counsel, Secretary $897K Aug 15, 2024
Lisa Locklear Chief Financial Officer $451K Aug 15, 2024
Nataliya Agafonova Chief Medical Officer $429K Aug 15, 2024
Mohamed Wa'el Ahmed Hashad Chief Executive Officer $271K Aug 15, 2024
Kwan-Hong Christopher Min Chief Medical Officer $199K Apr 4, 2022
Geoff Green Ceo $175K Apr 4, 2022
Khoso Baluch Director $80.2K +$14.3K +21.6% Aug 15, 2024
James Clavijo CFO and Treasurer $61.9K Jun 27, 2023
Neil E. Hare Director $50.8K Aug 15, 2024
Ursula Ungaro Director $40.3K Aug 15, 2024
Richard N. Kender Director $23.3K May 10, 2024
Jeffrey Pfeffer Director $20.3K +$13.5K +200% Dec 28, 2023
Cathy Ross Director $13.1K +$6.55K +100% Jan 10, 2024
Todd Girolamo Director $6.55K Dec 21, 2022
Roger Joseph Hajjar Director $0 Jul 2, 2024
Neha J. Motwani Director $0 Jul 2, 2024
Ds Med Llc 10%+ Owner May 17, 2022
Erin Borger Director Dec 21, 2022
Douglas W. Losordo Director Dec 21, 2023

Recent Insider Transactions by Companies or Individuals for Longeveron Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.